Variables | Univariate | Multivariate | |||||
---|---|---|---|---|---|---|---|
OR | 95% CI | p-value | OR | 95% CI | p-value | ||
Age (yr) | 64≥ | Ref | |||||
64< | 3.13 | (0.74–13.20) | 0.120 | ||||
Gender | Male | Ref | |||||
Female | 1.93 | (0.46–8.16) | 0.370 | ||||
Performance status | 0, 1 | Ref | |||||
2, 3 | 3.48 | (0.51–23.89) | 0.204 | ||||
Diabetes mellitus | Negative | Ref | |||||
Positive | 1.07 | (0.25–4.64) | 0.930 | ||||
Cardiovascular or neurologic disease | Negative | Ref | |||||
Positive | 3.00 | (0.71–12.69) | 0.136 | ||||
Immunocompromised status | Negative | Ref | |||||
Positive | 2.40 | (0.20–29.10) | 0.492 | ||||
History of urinary tract abnormalities | Negative | Ref | |||||
Positive | 1.21 | (0.15–9.82) | 0.860 | ||||
CCI scores | 0–2 | Ref | |||||
≥3 | 5.87 | (1.00–34.39) | 0.050 | ||||
Serum creatinine (mg/dL) | 1.26≥ | Ref | |||||
1.26< | 3.39 | (0.80–14.32) | 0.096 | ||||
Leukocyte counts (×103/μL) | 13.1≥ | Ref | |||||
13.1< | 3.13 | (0.74–13.20) | 0.120 | ||||
C-reactive protein (mg/dL) | 10.83≥ | Ref | |||||
10.83< | 1.20 | (0.32–4.45) | 0.785 | ||||
Platelet counts (×104/μL) | 15.0≤ | Ref | Ref | ||||
15.0> | 15.95 | (3.00–84.92) | 0.001 | 3.23 | (0.39–26.64) | 0.276 | |
Serum albumin (g/dL) | 3.1≤ | Ref | Ref | ||||
3.1> | 5.54 | (1.38–22.24) | 0.016 | 1.21 | (0.15–9.82) | 0.860 | |
PCT (ng/mL) | 23.55≥ | Ref | Ref | ||||
23.55< | 30.67 | (5.75–163.67) | < 0.001 | 13.12 | (1.41–122.03) | 0.024 | |
PSEP (pg/mL) | 515≥ | Ref | Ref | ||||
515< | 23.33 | (2.73–198.87) | 0.004 | 13.13 | (1.07–161.45) | 0.044 |